NASDAQ:LRMR

Larimar Therapeutics Stock News

etoro logo Buy LRMR
*Your capital is at risk
$4.11
+0.130 (+3.27%)
At Close: Aug 04, 2026
Olympic Steel, Inc. (Nasdaq: ZEUS), a leading national metals service center, invites you to participate in its conference call to discuss 2020 third-
Shares of CTI BioPharma Corp (NASDAQ:CTIC) gapped up prior to trading on Wednesday after Needham & Company LLC raised their price target on the stock from $3.50 to $6.00. The stock had previously clos
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.20%
Sep 22, 2020 (The Expresswire) -- Global “Follicular Lymphoma Treatment Market” Report discusses about the important developments impacting and increasing...
Olympic Steel Inc. (Nasdaq: ZEUS), a leading national metals service center, today announced that Damon J. Wos has joined the Company as General Manag
The following slide deck was published by Larimar Therapeutics, Inc. in conjunction with this event..
* Merger between Chondrial Therapeutics and Zafgen completed and company began operating as Larimar Therapeutics * Phase 1 clinical trial of CTI-1601 for treatment of Friedreich’s ataxia restarts a
Humanigen, Inc., (HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating cytokine storm with lenzilumab, t
3CLogic, a leading provider of cloud contact center solutions, today announced the adoption of its telephony platform integrated with ServiceNow’s® Cu
Composite Technology International (CTI) has announced that Todd Stemler has been named CFO replacing Rande Willison, who previously held this role with the company. This role will be managed from the
BALA CYNWYD, Pa., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Nasdaq:LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today
BALA CYNWYD, Pa., July 28, 2020 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Nasdaq:LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today
Biohaven completes enrollment in Phase 3 clinical trial for Multiple System Atrophy. Lexicon Pharma reports positive late stage studies data.
BALA CYNWYD, Pa., July 20, 2020 -- Larimar Therapeutics, Inc. (Nasdaq:LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE